← Home UAE · nd-uae

Sisram Medical Announces NMPA Acceptance of Profhilo Registration Application for Facial Indication

Source: en_prnasisa · 2026-10-19T19:30:00 UTC

Advancing Commercialization Preparations to Expand Injectables Presence in China HONG KONG, Oct. 20, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-Based Devices ("EBD"), injectables, and other complementary solutions, today announced China's National Medical Products Administration ("NMPA") had formally accepted the registrati

Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.

Read full story on publisher site →

Sisram Medical Announces NMPA Acceptance of Profhilo Registration Application for Facial Indication

Related in UAE

Dubai court: Seller of Dh35 million licence plate loses Dh25 million claim - no written proof of the full price

Basilea Reports Presentation Of New Data For Fosmanogepix, Isavuconazole And Ceftobiprole At Idweek 2026

Olympic Champion Tola Smashes Beijing Marathon Course Record

Fixed Deposit Planning Made Easy With A Fixed Deposit Interest Rate Calculator

Dray Dog Integrates With Cargowise Transport Management Systems, Streamlining Port Appointments For Drayage Operators

Dihydrotestosterone (DHT): Beyond Hair Loss - Key Regulator Across Multiple Disease Pathways